ResearcherHarvard UniversityNo recent work listed

Towia A. Libermann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4006-8179; OpenAlex author ID A5082987136; NIH RePORTER profile ID 1864113. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 grant

Papers 1

Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. Last author DOI 10.18632/oncotarget.8139 ↗

Grants 1

Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology R21CA218960 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea J. Bullock · 1 shared paper, 2016 · strength 0.05
- Paper Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. DOI 10.18632/oncotarget.8139 ↗
Peng Zhang · 1 shared paper, 2016 · strength 0.05
- Paper Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. DOI 10.18632/oncotarget.8139 ↗
Rebecca Anne Miksad · 1 shared paper, 2016 · strength 0.05
- Paper Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. DOI 10.18632/oncotarget.8139 ↗
Manoj Bhasin · 1 shared paper, 2016 · strength 0.05
- Paper Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. DOI 10.18632/oncotarget.8139 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.